Palisade Bio (PALI) Other Non-Current Liabilities (2016 - 2025)
Historic Other Non-Current Liabilities for Palisade Bio (PALI) over the last 14 years, with Q3 2025 value amounting to $283000.0.
- Palisade Bio's Other Non-Current Liabilities rose 52888.89% to $283000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $283000.0, marking a year-over-year increase of 52888.89%. This contributed to the annual value of $150000.0 for FY2024, which is 1450.38% up from last year.
- Palisade Bio's Other Non-Current Liabilities amounted to $283000.0 in Q3 2025, which was up 52888.89% from $75000.0 recorded in Q2 2025.
- In the past 5 years, Palisade Bio's Other Non-Current Liabilities ranged from a high of $20.5 million in Q2 2021 and a low of $2000.0 during Q2 2023
- For the 5-year period, Palisade Bio's Other Non-Current Liabilities averaged around $1.9 million, with its median value being $160601.0 (2021).
- Its Other Non-Current Liabilities has fluctuated over the past 5 years, first soared by 3267709.47% in 2021, then crashed by 9957.36% in 2023.
- Over the past 5 years, Palisade Bio's Other Non-Current Liabilities (Quarter) stood at $9.4 million in 2021, then crashed by 98.09% to $180000.0 in 2022, then fell by 27.22% to $131000.0 in 2023, then grew by 14.5% to $150000.0 in 2024, then soared by 88.67% to $283000.0 in 2025.
- Its Other Non-Current Liabilities stands at $283000.0 for Q3 2025, versus $75000.0 for Q2 2025 and $80000.0 for Q1 2025.